Phylogeographic Analysis of Mycobacterium kansasii Isolates from Patients with M. kansasii Lung Disease in Industrialized City, Taiwan
Patrick George Tobias Cudahy, Po-Chen Liu, Joshua L. Warren, Benjamin Sobkowiak, Chongguang Yang, Thomas R. Ioerger, Chieh-Yin Wu, Po-Liang Lu, Jann-Yuan Wang, Hsiao-Han Chang, Hung-Ling Huang
, Ted Cohen, and Hsien-Ho Lin
Author affiliations: Yale School of Medicine, New Haven, Connecticut, USA (P.G.T. Cudahy); National Taiwan University, Taipei, Taiwan (P.-C. Liu, C.-Y. Wu, J.-Y. Wang, H.-H. Lin); Yale School of Public Health, New Haven (J.L. Warren, B. Sobkowiak, T. Cohen); Sun Yat-Sen University School of Public Health, Guangzhou, China (C. Yang); Texas A&M University, College Station, Texas, USA (T.R. Ioerger); Kaohsiung Medical University, Kaohsiung, Taiwan (P.-L. Lu, H.-L. Huang); Kaohsiung Medical University Hospital, Kaohsiung (P.-L. Lu, H.-L. Huang); National Tsing Hua University, Hsinchu, Taiwan (H.-H. Chang); Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung (H.-L. Huang)
Main Article
Figure 3
Figure 3. Maximum-likelihood phylogram of clinical Mycobacterium kansasii isolates from patients with M. kansasii lung disease in industrialized city, Taiwan. Phylogeny with major clades are labeled as A, B, and C; colored text indicates source of water for patient households.
Main Article
Page created: June 18, 2024
Page updated: July 20, 2024
Page reviewed: July 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.